Theris Emerges From Stealth With AI-Augmented Behavioral Health Platform
The company employs its own clinicians while also partnering with external providers using the platform. Among its major clients is the Department of Veterans Affairs.
Theris, an AI-augmented behavioral health provider, has emerged from stealth mode with an updated platform designed to automate clinical workflows and support mental health providers with artificial intelligence tools.
Founded in 2023, the company provides behavioral healthcare services while integrating AI across intake, documentation, billing, and treatment support. Theris said its platform is currently operating across eight states, with a focus on memory care and substance use disorder treatment.
The company employs its own clinicians while also partnering with external providers using the platform. Among its major clients is the Department of Veterans Affairs.
During patient sessions, AI agents record and analyze conversations with patient consent. According to Theris, the system can identify missed clinical details, flag potential medication interactions, and generate structured clinical documentation directly within electronic health records.
The platform also extracts digital biomarkers from voice cadence and facial micro-expressions to generate treatment recommendations. Theris claims early data showed AI-augmented sessions achieved 94% diagnostic accuracy when compared to human psychology assessments.
In addition, the platform monitors patient resistance during therapy sessions and alerts providers to adjust their approach when needed. Theris also uses AI-generated patient avatars to help clinicians practice psychiatric intake and simulate complex treatment scenarios.
The company said anonymized recordings from more than 150,000 hours of clinical encounters have been used to train its AI models. Theris aims to expand that dataset to 1 million hours next year. The models are built on the open-source Qwen foundational model and are tailored for specific psychiatric diagnostic categories.
Theris also captures webcam-derived vitals, including heart rate and breathing rate, without requiring wearable devices. Between appointments, patients receive daily symptom check-ins through the platform.
The startup said less than 1% of patients opt out of session recordings. Theris stated that all recordings are anonymized for training purposes and are not shared externally.
The company’s next phase involves pursuing FDA Class II medical device status for autonomous psychology and psychiatry applications. CEO Anthony Capone said the company expects AI-delivered psychotherapy and psychiatry to eventually become reimbursable through commercial and government insurance programs.
Theris accepts commercial insurance, Medicaid, and Medicare plans in most operating states. The company recently said one of its practice group subsidiaries had been accepted into the CMS ACCESS model focused on value-based behavioral healthcare.
Stay tuned for more such updates on Digital Health News